A Single, Dose Escalation, Optimal Dose Finding Phase I/IIa Clinical Trial to Evaluate Safety and Explore Efficacy of the Single Treatment of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis
Latest Information Update: 18 Jul 2023
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy-Kangstem Biotech (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Sponsors Kangstem Biotech
Most Recent Events
- 18 Jul 2023 New trial record